Revolution Medicines, Inc. financial data

Symbol
RVMD, RVMDW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Saginaw Dr, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.53K % +22%
Debt-to-equity 12 % -15.5%
Return On Equity -33.5 % +12.9%
Return On Assets -29.9 % +11.2%
Operating Margin -88K % -6144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 186M shares +12.7%
Common Stock, Shares, Outstanding 186M shares +12.9%
Entity Public Float 6.5B USD +136%
Common Stock, Value, Issued 18K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 168M shares +48.2%
Weighted Average Number of Shares Outstanding, Diluted 168M shares +48.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 592M USD +40%
General and Administrative Expense 97.3M USD +28.7%
Operating Income (Loss) -690M USD -41.5%
Nonoperating Income (Expense) 88.7M USD +87.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -601M USD -36.6%
Income Tax Expense (Benefit) -753K USD +78.6%
Net Income (Loss) Attributable to Parent -600M USD -37.5%
Earnings Per Share, Basic -3.58 USD/shares +7.25%
Earnings Per Share, Diluted -3.58 USD/shares +7.25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 543M USD -22%
Marketable Securities, Current 1.75B USD +51%
Assets, Current 2.33B USD +23.9%
Property, Plant and Equipment, Net 24.3M USD +6.23%
Operating Lease, Right-of-Use Asset 118M USD +52.3%
Intangible Assets, Net (Excluding Goodwill) 56.7M USD -1.85%
Goodwill 14.6M USD 0%
Other Assets, Noncurrent 13.9M USD +97.2%
Assets 2.56B USD +24.1%
Accounts Payable, Current 54.4M USD -11.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 164M USD +13.9%
Deferred Income Tax Liabilities, Net 2.35M USD -24.5%
Operating Lease, Liability, Noncurrent 123M USD +52.6%
Other Liabilities, Noncurrent 670K USD -54%
Liabilities 293M USD +24.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.32M USD +143%
Retained Earnings (Accumulated Deficit) -1.74B USD -52.7%
Stockholders' Equity Attributable to Parent 2.27B USD +24%
Liabilities and Equity 2.56B USD +24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -161M USD -157%
Net Cash Provided by (Used in) Financing Activities 810K USD -99.8%
Net Cash Provided by (Used in) Investing Activities -248M USD -6305%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 186M shares +9.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -408M USD -253%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 547M USD -21.8%
Deferred Tax Assets, Valuation Allowance 564M USD +49.7%
Deferred Tax Assets, Gross 609M USD +50.9%
Operating Lease, Liability 136M USD +54.5%
Depreciation 6.2M USD +24%
Payments to Acquire Property, Plant, and Equipment 3.17M USD +80.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -599M USD -38.1%
Lessee, Operating Lease, Liability, to be Paid 216M USD +48.7%
Property, Plant and Equipment, Gross 46.1M USD +13.7%
Operating Lease, Liability, Current 12.9M USD +74.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17M USD +62.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.1M USD +133%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 73.7M USD +28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.6M USD +61.9%
Deferred Tax Assets, Operating Loss Carryforwards 227M USD +53.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 206M USD +7.73%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.7M USD +57.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.07M USD +0.09%
Deferred Tax Assets, Net of Valuation Allowance 45.1M USD +67.7%
Share-based Payment Arrangement, Expense 79.2M USD +28.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%